PUBLISHED: 23 Aug 2024 at 06: 10
In response to growing concerns about the spread of the viral infection, the Food and Drug Administration ( FDA ) has approved the sale of mpox diagnostic test kits.
Lertchai Lertwut, FDA assistant secretary-general, said on Thursday that the FDA is streamlining the system subscription method for companies and manufacturers.
This is being done, according to Mr. Lertchai, to facilitate registration approval, maintain the proper availability of the kits, and protect public health security.
He said more details about the FDA-approved kits can be found at the website https ://medical .fda.moph.go.th
Before registering their goods, Mr. Lertchai advised suppliers and buyers of mpox kits to call the FDA for the item registration rules.
FDA’s announcement follows the World Health Organization’s ( WHO ) recent declaration of a new strain of mpox, the Clade 1b-type, as a “public health emergency international concern” after cases were found in more than 10 African countries.
The new strain’s spread, according to Dr. Darinda Rosa, acting director of the Office of Disease Prevention and Control 11 in Nakhon Si Thammarat, has caused WHO to be concerned because it is more transmissible than the previous pressure.
More than 15, 600 people worldwide have been diagnosed with the fresh mpox burden, with 537 mortality.
142 people were identified with the new mpox burden in Thailand between Jan 1 and Aug 17 according to Dr. Darinda. The popular illness has claimed the lives of three individuals in the country.
The Department of Disease Control has mandated that travelers from Africa be checked out of international airports, especially Don Mueang and Suvarnabhumi terminals and Laem Chabang Port.